IOR: Andrea Alimonti appointed as new Director

Prof. Andrea Alimonti has been appointed the new Director of the Institute of Oncology Research (IOR, a member of Bios+ and affiliated with USI) in Bellinzona. He will take over from Prof. Carlo Catapano, who is leaving the leadership of the IOR after 20 years due to reaching retirement age. The IOR Foundation has selected Prof. Andrea Alimonti  as the new Director of IOR starting from 1 January 2024. This decision was made based on the recommendation put forth by the Council of the Università della Svizzera italiana during their meeting on Thursday, 11 May. Prof. Alimonti will succeed Prof. Carlo Catapano , who, after 20 years, will leave this role and retire while remaining head of the  Experimental Therapeutics Research Group. Under Carlo Catapano's leadership, IOR, founded in 2003, has grown steadily in both numbers and quality. Suffice it to say that in 2011 IOR had only three research groups.